FDA Panel Endorses Imetelstat for MDS-Related Anemia

(MedPage Today) -- An FDA panel overwhelmingly backed investigational imetelstat as a treatment option for transfusion-dependent anemia in adults with lower-risk myelodysplastic syndromes (MDS) who failed on erythropoiesis-stimulating agents (ESAs...
Source: MedPage Today Public Health - Category: American Health Source Type: news